|
|
|
瑞銀(盧森堡)生化股票基金
(美元)
| 幣別 |
淨值 |
漲跌 |
漲跌比例 |
日期 |
| 美元 |
676.64 |
-0.91 |
-0.13% |
2020/02/14 |
|
|
| 2010 |
2011 |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
| 14.32% |
1.85% |
32.71% |
54.62% |
41.28% |
1.57% |
-17.08% |
25.45% |
-13.98% |
29.08% |
| 瑞銀(盧森堡)生化股票基金(美元)
| |
本基金主要投資於全球生化科技產業中從事研究、產品開發、產品製造及配銷的公司股票;選股著重於個別公司之市場地位及該公司之管理與獲利能力，以獲得來自該產業的利益。本基金的投資目標在於透過積極的基金管理方式，達到最佳之投資績效，同時將投資風險降至最低。
|
| 日期 |
淨值 |
漲跌比例 |
日期 |
淨值 |
漲跌比例 |
| 2020/02/14 |
676.64 |
-0.13% |
2020/01/31 |
630.81 |
-1.24% |
| 2020/02/13 |
677.55 |
-0.82% |
2020/01/30 |
638.75 |
-1.10% |
| 2020/02/12 |
683.13 |
0.59% |
2020/01/29 |
645.88 |
0.14% |
| 2020/02/11 |
679.11 |
0.17% |
2020/01/28 |
644.98 |
-1.55% |
| 2020/02/10 |
677.94 |
1.58% |
2020/01/22 |
655.11 |
-1.73% |
| 2020/02/07 |
667.37 |
-0.37% |
2020/01/17 |
666.65 |
-0.04% |
| 2020/02/06 |
669.84 |
0.31% |
2020/01/16 |
666.95 |
0.11% |
| 2020/02/05 |
667.76 |
1.75% |
2020/01/15 |
666.23 |
0.63% |
| 2020/02/04 |
656.29 |
2.29% |
2020/01/14 |
662.05 |
2.32% |
| 2020/02/03 |
641.59 |
1.71% |
2020/01/13 |
647.04 |
-1.86% |
基金績效 (可點按欄位名稱排序)
| 名稱 |
一日 |
一週 |
一個月 |
三個月 |
六個月 |
一年 |
今年以來 |
|
-0.13% |
1.39% |
2.20% |
12.44% |
21.19% |
13.97% |
3.20% |
| NBI生技指數 |
0.77% |
0.48% |
1.37% |
8.95% |
17.59% |
10.82% |
2.46% |
| 費城藥物指數 |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| AMEX生技指數 |
0.90% |
0.98% |
2.55% |
12.54% |
16.43% |
6.73% |
4.76% |
| MSCI 全球醫療保健指數 (price) |
0.00% |
-0.65% |
-0.32% |
7.19% |
15.19% |
15.14% |
2.25% |
| MSCI 製藥指數 (price) |
0.00% |
-1.34% |
-1.92% |
7.23% |
13.81% |
12.36% |
0.81% |
| MSCI 生物科技指數 (price) |
0.00% |
-0.85% |
3.25% |
7.55% |
21.66% |
15.33% |
4.14% |
|
0.20% |
-0.17% |
-0.74% |
5.99% |
14.53% |
11.87% |
2.17% |
|
0.20% |
-0.19% |
-0.82% |
5.73% |
13.96% |
10.77% |
2.04% |
|
0.16% |
0.65% |
3.25% |
13.99% |
23.47% |
16.39% |
4.75% |
|
0.35% |
1.19% |
1.69% |
9.38% |
11.90% |
7.12% |
1.63% |
|
0.47% |
1.25% |
3.11% |
12.49% |
18.40% |
24.62% |
7.28% |
|
0.19% |
0.23% |
0.38% |
10.07% |
15.50% |
18.96% |
3.35% |
|
0.44% |
0.65% |
1.35% |
10.12% |
16.71% |
16.62% |
4.31% |
|
0.18% |
1.07% |
2.42% |
6.41% |
7.01% |
9.57% |
3.23% |
|
0.14% |
1.30% |
2.01% |
8.29% |
11.81% |
12.43% |
3.42% |
|
-1.41% |
-0.17% |
-5.27% |
-1.77% |
16.41% |
28.83% |
-5.56% |
|
-0.27% |
1.07% |
3.21% |
11.61% |
16.79% |
24.56% |
7.24% |
|
0.33% |
-0.57% |
1.48% |
13.63% |
20.50% |
17.02% |
3.05% |
|
0.36% |
-0.60% |
1.36% |
13.27% |
19.70% |
15.54% |
2.88% |
|
0.00% |
0.55% |
-0.39% |
9.75% |
18.25% |
18.60% |
1.20% |
|
0.15% |
-0.15% |
0.64% |
9.45% |
15.90% |
15.36% |
1.86% |
|
0.12% |
-0.19% |
0.56% |
9.18% |
15.31% |
14.21% |
1.70% |
|
0.11% |
-0.20% |
0.42% |
8.74% |
14.23% |
11.80% |
1.51% |
|
0.11% |
-0.20% |
0.49% |
8.93% |
14.66% |
12.66% |
1.60% |
|
0.15% |
-0.15% |
0.71% |
9.67% |
16.33% |
16.24% |
1.94% |
|
-0.11% |
0.33% |
1.65% |
7.93% |
11.23% |
10.90% |
2.32% |
|
0.29% |
-0.82% |
0.80% |
10.30% |
15.43% |
11.63% |
2.78% |
|
0.76% |
0.24% |
3.73% |
13.65% |
19.95% |
19.98% |
7.00% |
|
0.31% |
-0.78% |
0.99% |
10.98% |
17.05% |
15.08% |
3.09% |
|
-0.09% |
0.33% |
0.42% |
5.27% |
9.85% |
9.27% |
1.81% |
|
0.37% |
1.40% |
3.35% |
8.51% |
14.18% |
17.49% |
6.02% |
|
-0.07% |
0.37% |
0.63% |
5.96% |
11.42% |
12.69% |
2.14% |
|
-0.03% |
0.77% |
0.82% |
9.37% |
16.99% |
20.08% |
1.92% |
|
0.00% |
0.51% |
4.21% |
15.79% |
22.47% |
22.22% |
7.80% |
|
0.00% |
0.23% |
0.95% |
13.26% |
22.00% |
19.27% |
4.15% |
| 基金平均績效 |
0.11% |
0.31% |
1.19% |
9.61% |
16.10% |
15.86% |
3.06% |
* 基金報酬率包含配息
(若未註明"*"，則基金報酬率不包含配息，對於有配息之基金，將造成總報酬率數值低估。)
本資訊僅供參考，實際數據以官方公佈資料為準。 本站自當盡力為使用者提供正確的意見及消息，但如有錯漏或疏忽，本站恕不負任何法律責任。
|
